The objective of the research proposed is to determine, at the nucleotide sequence level, the nature of a temperature-sensitive (for transformation) mutant of wild-type MuSV-349 virus designated ts110. Ts110 MuSV-infected cells and rescue of ts110 MuSV virions contain two viral RNAs which are deleted relative to wild-type MuSV-349 RNA. We will determine the number of indicated proviruses from which these RNAs arise. These ts110 provirus(es) will be molecularly cloned and sequenced to yield details on the extent of the mutation. Similarly, ts110 MuSV viral RNAs will be analyzed by S-1 nuclease mapping techniques as well as primer extension techniques to provide details on the positions of the deletion boundaries and the nucleotide sequence of these boundaries. If, as is our present interpretation, the smaller (3.5 kb) ts110 RNA arises by splicing of the larger (4.0 kb) transcript, these analyses will yield crucial data on the position of the proposed splice and whether it in fact is bounded by splice donor and acceptor sequences. Since the deletion(s) appear to include approximately the first 100 nucleotides in the mos gene, the S-1 and primer extension data should provide convincing data on this point also. There are revertants of ts110 MuSV available (infected cells transformed at both temperatures) in which a single 4.0 kb viral RNA is found and which produce a novel 100kd gag-mos fusion protein. Cloning of these proviruses, as well as S-1 and primer extension analysis will be performed and should prove instructive in our interpretation of the original mutation. Finally, we intend to study the biological activity of the MuSVts110 RNAs and cloned ts110 MuSV DNAs by microinjection into animal cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034734-03
Application #
3172518
Study Section
Experimental Virology Study Section (EVR)
Project Start
1983-06-01
Project End
1986-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Ainsworth, J R; Rossi, L M; Murphy Jr, E C (1996) The Moloney murine sarcoma virus ts110 5' splice site signal contributes to the regulation of splicing efficiency and thermosensitivity. J Virol 70:6474-8
Touchman, J W; D'Souza, I; Heckman, C A et al. (1995) Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotype. J Virol 69:7724-33
Sterner, D A; Murphy Jr, E C (1992) Regulation of the efficiency and thermodependence of murine sarcoma virus MuSVts110 RNA splicing by sequences in both exons. Virology 191:638-48
Huai, L; Chiocca, S M; Gilbreth, M A et al. (1992) Moloney murine sarcoma virus MuSVts110 DNA: cloning, nucleotide sequence, and gene expression. J Virol 66:5329-37
Owen-Schaub, L B; de Mars, M; Murphy Jr, E C et al. (1991) IL-2 dose regulates TNF-alpha mRNA transcription and protein secretion in human peripheral blood lymphocytes. Cell Immunol 132:193-200
Chiocca, S M; Sterner, D A; Biggart, N W et al. (1991) Nickel mutagenesis: alteration of the MuSVts110 thermosensitive splicing phenotype by a nickel-induced duplication of the 3' splice site. Mol Carcinog 4:61-71
de Mars, M; Cizdziel, P E; Murphy Jr, E C (1990) Activation of cryptic splice sites in murine sarcoma virus-124 mutants. J Virol 64:5260-9
De Mars, M; Sterner, D A; Chiocca, S M et al. (1990) Regulation of RNA splicing in gag-deficient mutants of Moloney murine sarcoma virus MuSVts110. J Virol 64:1421-8
Owen-Schaub, L B; De Mars, M; Murphy Jr, E C et al. (1990) TNF-beta (lymphotoxin) strongly upregulates TNF-alpha gene expression in human peripheral blood lymphocytes. Lymphokine Res 9:491-7
Biggart, N W; Murphy Jr, E C (1988) Analysis of metal-induced mutations altering the expression or structure of a retroviral gene in a mammalian cell line. Mutat Res 198:115-29

Showing the most recent 10 out of 17 publications